AOL27 天
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
On Tuesday, Repligen Corporation (NASDAQ:RGEN) purchased 908 Devices Inc.’s (NASDAQ:MASS) desktop portfolio of four devices for bioprocessing process analytical technology (PAT) applications.